Food of the United States And the FDA on Wednesday approved a new obesity pill called Foundive. Taken once a day, the pill is made by the pharmaceutical company Eli Lilly, which also produces the popular weight loss injection Zepbound. Foundayo is a type of drug known as GLP-1, a category that includes competitors Ozympic … Read more
cry! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also helps with weight loss. Known as “triple-G,” injectable retatretide has triple hits on the GLP-1, GIP, and glucagon hormones, while most other drugs on the market only mimic one or two of these hormones. Eli Lilly’s new retatretide drug … Read more
Millions of Britons use GLP-1 weight loss drugs to change how they drink, eat and choose places. For the beverage business, the shift may be to examine the revenue models generated by alcohol. For anyone inclined to view GLP 1 drugs in hospitality as someone else’s concern, the numbers already suggest otherwise. According to KAM, … Read more
Moderate-to-high-quality evidence from umbrella reviews on non-cardiometabolic outcomes supported associations between GLP-1 therapy and risks of nausea, vomiting, and diarrhea. High-quality evidence indicates a possible protective association between GLP-1 medication and infection-related outcomes, particularly serious infections. Exploratory indications also suggest a possible reduction in the risk of falls, respiratory disease events, and all-cause dementia. A … Read more
Create Wellness on Monday launched Creatine + Electrolyte Mix, available on Create’s website, Amazon, and in-store exclusively at Target. Create prosperity Create Wellness, the creatine gummy supplement brand, has raised $20 million in new funding amid a long-term rise in the American fitness and muscle building supplement market. The round was led by Allied Consumer … Read more
The U.S. Food and Drug Administration announced Thursday that it is approving a new, high-dose Vigovi (semglutide) injection. The 7.2 mg dose, called Vigovi HD, is intended for weight loss and long-term weight loss maintenance in adult patients. This is three times the previous maximum dose of 2.4 mg. This marks the fourth approval in … Read more